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Food hypersensitivity is believed to affect 1.5% of adults and
6–8% of children (1–7) and vary widely according to the
populations studied for most foods (8). Peanut is reported as
the most common food causing severe IgE-mediated reac-
tions in children and adolescents in the USA and Europe (9,
10).
In the UK three studies reported on the prevalence of pea-
nut allergy(11, 12). On the Isle of Wight the prevalence of
peanut allergy has been reported to be 1% in 11 year olds
and 0.8% in 15 year olds, (7) with a peanut sensitization of
0.4% in 1 year olds (6). Hourihane et al. (11) reported
recently, a peanut allergy prevalence rate of 1.8% in 5-year-
old children in the UK. In addition Du Toit et al. (12)
reported a prevalence of self-reported peanut allergy in 4–18-
year-old children in the UK of 1.85%.
Based on the Isle of Wight data, we have previously
reported an increase in the prevalence in peanut sensitization
and clinical allergy between two cohorts of children born
6 years apart (13). This study reports on the prevalence of
peanut allergy in a cohort of children born in 2001–2002 and
seeks to determine whether the prevalence of peanut allergy
has changed since 1994–1996.
Methods
Three cohorts of children born on the Isle of Wight were
assessed at the David Hide Asthma and Allergy Research
Centre for peanut sensitization and clinical symptoms:
Cohort A: Born in 1989; reviewed at 4 years of age
(n = 2181).
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Abstract
Background: This article investigated the prevalence of peanut allergy in three
cohorts of children born in the same geographical location, Isle of Wight, UK and
seeks to determine whether the prevalence of peanut allergy has changed between
1994 and 2004.
Methods: Three cohorts of children (age 3–4 years) born on the Isle of Wight, were
assessed for peanut allergy and the outcomes compared: Cohort A: Born in 1989;
reviewed at 4 years of age (n = 2181).
Cohort B: Born between 1994 and 1996; reviewed between 3 and 4 years of age
(n = 1273).
Cohort C: Born between 2001 and 2002; reviewed at 3 years of age (n = 891).
Results: Peanut sensitization increased signiﬁcantly from 1.3% in Cohort A to 3.3%
(P = 0.003) in Cohort B before falling back to 2.0% in Cohort C (P = 0.145).
Similarly, clinical peanut allergy increased signiﬁcantly from 0.5% in Cohort A to
1.4% (P = 0.023) in Cohort B, with a subsequent fall to 1.2% in Cohort C
(P = 0.850).
Conclusions: Our data from three cohorts of 3- to 4-year-old children born in the
same geographical area shows that peanut allergy prevalence has changed over time.
Peanut sensitization and reported allergy in children born in 1994–1996 increased
from 1989 but seems to have stabilized or slightly decreased since the late 1990s,
although not signiﬁcant.
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Cohort B: Born between 1994 and 1996; reviewed between
3 and 4 years of age (n = 1273).
Cohort C: Born between 2001and 2002; reviewed at
3 years of age (n = 891).
Characteristics of Cohort A (14) and Cohort B (13, 15)
have previously been described.
In brief, for Cohort A, a birth cohort of 1456 children was
recruited over a 14-month period (1989–1990). At 4 years,
1218 (used as denominator for clinical allergy) children were
reviewed and 981 (used as denominator for sensitization)
children were skin prick tested (SPT) with a battery of 12
common allergens. For Cohort B, 2858 3- to 4-year-old chil-
dren were recruited into a study looking at food additives
and behaviour (15). Parents of 1273 children (used as denom-
inator for clinical allergy) agreed to participate in this study
looking at peanut allergy and 1246 (used as denominator for
sensitization) children consented to a SPT and were included
in the results for that article. Diagnosis of peanut allergy was
made by means of an open food challenge (OFC).
For Cohort C, 969 infants were recruited into a study
looking at the prevalence and cumulative incidence of food
hypersensitivity (5). Parents of 891 children (used as denomi-
nator for clinical allergy) agreed to participate in this study
looking at peanut allergy and 642 (used as denominator for
sensitization) children/parents consented to a SPT and were
included in the results for that article. Children were SPT to
a standard battery of allergens including house dust mite,
cat, grass, milk, egg, wheat, cod ﬁsh, sesame and peanut.
Skin prick tests were conducted with commercial extracts
obtained from Soluprick SQ allergens-ALK Allergologisk
Laboratorium A/S (Horsholm, Denmark). Similar SPT meth-
odology was used as for Cohort A and Cohort B. Diagnosis
of peanut allergy was made by means of an OFC. These pea-
nut challenges were only conducted at 3 years of age as it is
considered that infants should not be exposed to these foods
in the ﬁrst few years of life as recommended by the COT
report (5, 16) Those with a positive reaction were invited to
participate in a double-blind, placebo-controlled food chal-
lenge (DBPCFC) but none of the parents were prepared to
consent to this.
Approval for the study was obtained from the Isle of
Wight, Portsmouth and South East Hampshire Local
Research Ethics Committee (Ref 09/01).
The following deﬁnitions were used for the purpose of this
study:
Sensitization to peanuts: This was deﬁned as wheal size
‡3 mm in the presence of a negative control in all three
cohorts.
Clinical peanut allergy: This was deﬁned as a positive SPT
with a convincing clinical history or a positive OFC (Cohorts
B and C) that is all children sensitized to peanut who have
not eaten peanut underwent food challenges. In Cohort A,
the diagnosis of clinical peanut allergy was based on convinc-
ing clinical history alone and challenges were not performed.
Those who had a positive SPT in Cohort C, but who had
not eaten peanut at that stage, underwent speciﬁc IgE tests
and were followed by the Allergy Centre until they consumed
peanut without a reaction.
Overall atopy: This was deﬁned as a positive SPT (‡3 mm)
to any allergen that was tested in all three cohorts. These
included house dust mite, cat, grass, milk, egg and peanut.
Statistical analysis
All data were double entered by different operators on spss
versions 10 and 11 and were compared and veriﬁed (SPSS
Inc., Chicago, IL, USA). The incidence of sensitization and
allergy across the three cohorts was examined using Chi-
square tests in which the linear and quadratic components of
trend have been isolated. The effect of exposure to different
factors has been quantiﬁed using Odds Ratios with 95% con-
ﬁdence limits derived using conditional likelihood estimation.
Missing data was not included in the calculations.
Results
Sensitization status
For Cohort A, 1218 (88% of the original cohort) children
were reviewed at 4 years and 981 children were SPT (14).
Thirteen (1.3%; 13/981) were sensitized to peanut.
For Cohort B, 1273 children were seen at three years of
age and 1246 of this cohort were SPT to peanut (13). Forty
one (3.3%; 41/1246) children had a positive SPT to peanut.
In Cohort C, 891 children were reviewed at 3 years of age
(used as denominator for clinical allergy) and SPT were per-
formed on 642 (used as denominator for sensitization) chil-
dren. Thirteen children 2.0% (95% CI 1.08–3.43) were
sensitized to peanut.
Comparing the three cohorts, prevalence of sensitization to
peanut rose from 1.3% to 3.3% in Cohorts A and B
(P = 0.003) (Fig. 1) after which it fell back to 2.0%,
although the decline failed to reach statistical signiﬁcance
(P = 0.145).
For Cohort C, of the children sensitized to peanut, 53.9%
suffered from current wheeze (i.e. wheeze in the last
12 months) and 61.5% were diagnosed with eczema in the
past (Table 1). Parents of children sensitized to peanut were
signiﬁcantly more likely to report their children having
wheezed in the last 12 months (P = 0.012) and eczema in
the past (P = 0.002). They were also commonly sensitized to
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Figure 1 Comparison of sensitization to peanuts in three cohorts
of children aged 3–4 years. *Test for trend: Chi-square (quadratic
component) P = 0.005.
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other allergens (Table 2). Children sensitized to peanut were
signiﬁcantly more likely to be sensitized to House Dust Mite
(P < 0.001), Cat (P = 0.013), Egg (P < 0.001) and Sesame
(P < 0.001) than children not sensitized to peanut.
Children who were diagnosed with eczema over the course
of the 3 years, were signiﬁcantly more likely to be sensitized
to house dust mite (P < 0.001), cat (P = 0.007), egg
(P < 0.001), peanut (P = 0.001) and sesame (P = 0.006)
(Table 3). Children who were sensitized to egg were also
more likely to be sensitized to house dust mite (P < 0.001),
cat (P = 0.004) and peanut (P < 0.001), but not sesame
(P > 0.999) (Table 4).
Clinical diagnosis
For Cohort A, 6 of 1218 (0.5%) children were diagnosed
with peanut allergy based on their sensitization status
and clinical history and for Cohort B 18 children (1.4%; 18/
1273) were diagnosed with peanut allergy based on food chal-
lenge/clinical history and sensitization status.
For Cohort C, 13/642 were sensitized to peanut and 11/
891 (1.2%; 11/891) children were diagnosed with peanut
allergy. Three children were diagnosed by means of a
positive OFC. Eight children were not challenged due to a
convincing history of clinical reaction coupled with positive
skin prick test (SPT size: 4.25, 6, 6, 8, 9, 10, 12 and
11 mm). There was no difference in the number of breast-
feeding mothers or mothers who reported avoiding peanuts
during breastfeeding between those sensitized to peanut or
not.
Comparing the three cohorts, clinical peanut allergy
increased signiﬁcantly from 0.5% to 1.4% in Cohort A and
B (P = 0.023) with a subsequent fall to 1.2%, although this
was not statistically signiﬁcant (P = 0.850) (Fig. 2).
Overall atopy
In Cohort A, 12.3% (150/1218) children were diagnosed with
overall atopy, 15% in Cohort B (185/1246) and 11.7% (75/
642) in Cohort C.
There was no signiﬁcant difference when sequentially com-
paring the three groups (A vs B and B vs C) (Fig. 3) in terms
of overall atopy.
Table 1 Allergic morbidity amongst children sensitized to peanut compared to those not sensitized (Cohort C)
Allergic disorders
Sensitized to peanut,
(n = 13) (%)
Not sensitized to peanut,
(n = 629) (%) OR (95% CI) P-value
Ever wheeze 7 (53.8) 173 (27.5) 3.08 (0.87–11.22) 0.056
Wheeze in the last 12 months 7 (53.9) 136 (21.6) 4.23 (1.19–15.46) 0.012
Ever diagnosed eczema by a
doctor
8 (61.5) 127 (20.2) 6.32 (1.78–24.91) 0.002
Table 2 Atopic sensitization in children sensitized to peanut com-
pared to those not sensitized to peanuts (Cohort C)
Skin test
positivity
Sensitized
to peanut,
(n = 13)
(%)
Not
sensitized
to peanut,
(n = 629)
(%) OR (95% CI) P-value
House
dust mite
9 (69.2) 34 (5.4) 39.4 (10.2–134.4) <0.001
Grass 2 (15.4) 19 (3.0) 5.84 (0.6–29.5) 0.064
Cat 3 (23.1) 23 (3.7) 7.90 (1.3–33.3) 0.013
Milk 1 (7.7) 2 (0.3) 26.1 (0.4–521.1) 0.06
Egg 4 (30.8) 5 (0.8) 55.5 (9.1–298.5) <0.001
Wheat 1 (7.7) 7 (1.1) 7.40 (0.2–65.2) 0.152
Fish (cod) 3 (23.1) 0 (0) NA –
Sesame 5 (38.5) 4 (0.6) 97.7 (16.7–565.1) <0.001
Table 3 Atopic sensitization in children ever diagnosed with
eczema (Cohort C)
Skin test
positivity
Ever
diagnosed
with eczema
over 3 years
(n = 201) (%)
Not
diagnosed
with eczema
over 3 years
(n = 690) (%) OR (95% CI) P-value
House
dust mite
32 (15.9) 11 (1.6) 11.9 (5.9, 26.5) <0.001
Cat 12 (6.0) 14 (2.0) 3.1 (1.3, 7.3) 0.007
Egg 8 (4.0) 1 (0.15) 28.6 (3.8, 1270) <0.001
Peanut 9 (4.5) 4 (0.6) 8.0 (2.2, 36.0) 0.001
Sesame 6 (3.0) 3 (0.44) 7.0 (1.5, 43.8) 0.006
1.4
1.2
0.5
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
Cohorts A, B, C
%
 C
lin
ic
al
 P
ea
nu
t A
lle
rg
y 
*
6/1218
18/1273
11/891
Cohort A Cohort B Cohort C
Figure 2 Comparison of peanut allergy in three cohorts of children
aged 3–4 years. *Test for trend: Chi-square (quadratic component)
P = 0.127.
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Test for trend
We observed signiﬁcant changes in the levels of peanut sensi-
tization and overall atopy over time (Figs 1 and 3). In each
case the quadratic (nonlinear) components of trend were sta-
tistically signiﬁcant at conventional levels (with P-values
0.005, and 0.024, respectively). Although levels initially
increased from 1989 values (Cohort A) the data suggests that
this may have either peaked or started to decline, even
though the decline was not signiﬁcant. The trend in clinical
peanut allergy is less clear (Fig. 2). Using the entire cohort as
a denominator, neither the linear (0.069) nor quadratic
(0.127) components of trend achieve signiﬁcance at the 5%
level, although the data on the linear component could be
considered as borderline signiﬁcant.
Analysing the data using only the subgroup who under-
went SPT as the denominator, levels of clinical peanut allergy
did also not appear to be rising (P-value for quadratic
trend = 0.499). We feel, however, that this information,
using only those who underwent SPT, is spurious as only
72% of Cohort C consented to testing.
Discussion
In the most recent cohort of children born in 2001 (Cohort
C), we have found that 2.0% of children were sensitized to
peanut at the age of 3 years. Eleven (1.2%) of these
children were clinically allergic to peanuts based on food
challenge or sensitization status and a good clinical history.
In terms of sensitization to peanut, rates for children born
in 1989 were 1.3% (Cohort A) and 2.0% for children born
in 2001 (Cohort C) with a peak occurring in children
born in 1994–1996 (3.3%; Cohort B). Clinical peanut
allergy was slightly lower in Cohort C (1.2%) compared to
Cohort B (1.4%), with the lowest ﬁgures seen in Cohort A
(0.5%). However, the lowest ﬁgures for overall allergy were
seen in Cohort C (11.7%), followed by Cohort A (12.3%)
and Cohort B (14.8%).
Comparing the data from Cohort C with previous studies,
we found similar ﬁgures of clinical peanut allergy (1.3%), to
those reported by Sicherer (17) (0.8%) for the USA and
1.5% by Kagan (18) from Canada. Hourihane et al. (11) and
Du Toit et al. (12) recently reported a prevalence of peanut
allergy of 1.8% among 4- to 5-year-old and 1.85% in 4- to
18-year-old children in the UK, respectively. Although higher
than reported in our Cohort C (2.0% and 1.2%, respec-
tively), the differences between our Cohort C and that of Ho-
urihane et al. (11) are not statistically signiﬁcant (P = 0.28,
P = 0.34).
Parents of children in Cohort C sensitized to peanut, were
signiﬁcantly more likely to report suffering from other aller-
gic conditions such as eczema and wheeze, ﬁndings conﬁrmed
by Grundy et al. (13) and Hourihane et al. (11). This is inter-
esting, as Arshad et al. (19) found wheeze and asthma at
10 years of age to be associated with atopy (positive SPT) at
4 years of age, but not reported wheeze at 4 years. Sensitiza-
tion to peanut was also associated with sensitization to other
allergens (house dust mite, cat, egg and sesame). Grundy
et al. (13) reported similar ﬁndings. The signiﬁcance of these
associations is difﬁcult to interpret, that is, why peanut sensi-
tization is associated with sensitization to some foods but not
to others, for example milk, wheat or ﬁsh. However, the
association with house dust mite sensitization emphasizes
that peanut allergy is mostly present in atopic children.
House dust mite sensitization is often considered as a marker
for atopy (20).
Mean age of introduction to peanut in the study by Ho-
urihane et al. (11) was 36 months and Grundy (13) reported
18 months as the mean age of introduction. In Cohort C, the
mean age of introduction was 36 months, which indicates
later introduction of peanuts into the child’s diet in Cohort C
and the study performed by Hourihane et al. (11) than
Cohort B. This is in line with the COT report 1998 (16),
which advises that peanut should not be introduced into the
infant’s diet before the age of 3 years. Amongst the children
who were SPT to peanut at 3 years of age in Cohort C, we
had information regarding weaning practices of 628 children.
Of 13 children sensitized to peanut, ﬁve had eaten peanut
and six had not eaten peanut by 6 months of age; we did not
have data on two of the children.
Of the 617 children not sensitized to peanut, 215 had eaten
peanuts and 402 did not. There was no indication that age of
introduction of peanut played a role in sensitization
(P = 0.53).
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Figure 3 Comparison of overall atopy in three cohorts of children
aged 3–4 years. *Test for trend: Chi-square (quadratic component)
P = 0.024.
Table 4 Atopic sensitization to other aero- and food allergens in
children sensitized to egg (Cohort C)
Skin test
positivity
Sensitized
to egg
(n = 9)
(%)
Not
sensitized
to egg
(n = 633)
(%) OR (95% CI) P-value
House
dust mite
6 (66.7) 37 (5.9) 32.2 (6.5, 203.6) <0.001
Cat 3 (33.3) 23 (3.6) 13.3 (2.0, 66.1) 0.004
Peanut 4 (44.4) 9 (1.4) 55.5 (9.1, 298.5) <0.001
Sesame 0 (0) 9 (1.4) – >0.999
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We did not see any signiﬁcant changes (either increase or
decrease) in peanut allergy or sensitization since the release
of the COT report in the UK (16), although clinical allergy
in Cohort C was lower than for Cohort B but this was not
signiﬁcant. This information could be interpreted in two
ways. Firstly, one could argue that the lower levels of sensiti-
zation to peanut seen in Cohort C, compared to Cohort B
may merely be a reﬂection of the global trend (i.e. higher
rates of atopy in Cohort B compared to Cohorts A and C).
Also, it has to be considered that only 1273 of 2878 in
Cohort B consented to the medical questionnaire. It may
therefore be a highly selective population, but it was not pos-
sible to compare atopy between these two groups. One possi-
ble limitation of the study is that the children in Cohort A
did not undergo food challenges. These children have, how-
ever, been followed up for some time (21) and we are conﬁ-
dent that the ﬁgures reported based on history and
sensitization status are correct. Also, diagnosis based on clini-
cal history alone, without oral challenge, tends to over esti-
mate the prevalence of allergy and yet, Cohort A had the
lowest prevalence of clinical peanut allergy. In addition, some
people may argue that all the children in both Cohorts B and
C should have undergone DBPCFC rather than OFC. We
have recently reported that OFC in children with immediate
objective symptoms is adequate for diagnosing food allergy
(22). Interestingly, the only reason why all these children did
not undergo DBPCFC, was parental refusal. One advantage
of this study is the comparability of the population studies
born in the same geographical location, they were of similar
age and assessed by the same research team.
Conclusion
In summary, we have demonstrated in three cohorts of chil-
dren born in the same geographical area, Isle of Wight UK,
that sensitization to peanut and overall atopy have changed
since 1989, with a peak in children born in 1994–1996. No
signiﬁcant changes in clinical allergy appeared between 1994
and 2002. This may not necessarily be attributed to the
release of the COT report, as this advice was misunderstood
and applied incorrectly by both health care professionals and
pregnant women.
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